a developer of drugs to improve the treatment of cancer
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NBMTX | 19.63 | 0.27 | +1.39% |
Neuberger Berman Mid Cap Growth Tr | |||
NWJCX | 134.30 | 1.80 | +1.36% |
Nationwide NYSE Arca Tech 100 Idx A | |||
NPNAX | 48.36 | 0.52 | +1.09% |
Neuberger Berman Large Cap Value A | |||
JETNX | 15.99 | 0.14 | +0.88% |
Janus Henderson Global Sust Eq N | |||
HCMAX | 32.97 | 0.24 | +0.73% |
Hillman Value No Load |
A.I.dvisor indicates that over the last year, ABUS has been loosely correlated with ARRY. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ABUS jumps, then ARRY could also see price increases.
Ticker / NAME | Correlation To ABUS | 1D Price Change % | ||
---|---|---|---|---|
ABUS | 100% | +0.58% | ||
ARRY - ABUS | 43% Loosely correlated | -0.63% | ||
AXON - ABUS | 42% Loosely correlated | +3.52% | ||
ROIV - ABUS | 41% Loosely correlated | +2.87% | ||
VCYT - ABUS | 38% Loosely correlated | -0.66% | ||
VIR - ABUS | 38% Loosely correlated | +3.12% | ||
More |